(19)
(11) EP 4 348 260 A2

(12)

(88) Date of publication A3:
05.01.2023

(43) Date of publication:
10.04.2024 Bulletin 2024/15

(21) Application number: 22733495.0

(22) Date of filing: 03.06.2022
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
A61K 39/395(2006.01)
A61P 35/00(2006.01)
A61K 39/39(2006.01)
G01N 33/569(2006.01)
C07K 16/22(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/22; A61K 2039/505; A61K 2039/545; A61P 35/00
(86) International application number:
PCT/US2022/032278
(87) International publication number:
WO 2022/256723 (08.12.2022 Gazette 2022/49)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.06.2021 US 202163202260 P
14.07.2021 US 202163221588 P
14.07.2021 US 202163221843 P
18.10.2021 US 202163256927 P
10.01.2022 US 202263298128 P
25.01.2022 US 202263302999 P
24.02.2022 US 202263313355 P
24.02.2022 US 202263313386 P
25.03.2022 WO PCT/US2022/022063

(71) Applicant: Scholar Rock, Inc.
Cambridge, MA 02142 (US)

(72) Inventors:
  • GAN, Lu
    Cambridge, Massachusetts 02142 (US)
  • SCHURPF, Thomas
    Cambridge, Massachusetts 02142 (US)
  • CORICOR, George
    Cambridge, Massachusetts 02142 (US)
  • JACKSON, Justin
    Cambridge, Massachusetts 02142 (US)
  • LEE-HOEFLICH, Si Tuen
    Cambridge, Massachusetts 02142 (US)
  • BRUECKNER, Christopher
    Cambridge, Massachusetts 02142 (US)
  • MARTIN, Constance
    Cambridge, Massachusetts 02142 (US)
  • FAUCETTE, Ryan
    Cambridge, Massachusetts 02142 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) TGF-BETA INHIBITORS AND THERAPEUTIC USE THEREOF